Headlands Research is heading to the 4th Obesity & Weight Loss Drug Development Summit, July 14–16, in Boston. We're looking forward to connecting with sponsors and CROs on what's actually driving faster enrollment, stronger retention, and sharper execution in obesity trials.
If you'll be there, contact a member of our team to talk about how Headlands can support your next program:
• Lauren Chazal, Chief Business Development Officer
• Christopher Romero, Medical Director and Principal Investigator at Headlands Research Brownsville
• Taylor Gravitte, Account Manager